Mesalamine | Annual Sales Report

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 246

2016 Revenue in Millions : 415

Growth (%) : -41

Portfolio PDF

Product Web Link

Corporate PDF

02 Brand Name : Canasa/Salofalk

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 181

2016 Revenue in Millions : 196

Growth (%) : -8

Portfolio PDF

Product Web Link

Corporate PDF

03 Brand Name : Asacol/Delzicol

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 177

2017 Revenue in Millions : 246

Growth (%) : -28%

Portfolio PDF

Product Web Link

Corporate PDF

04 Brand Name : Canasa/Salofalk

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 187

2017 Revenue in Millions : 181

Growth (%) : 3%

Portfolio PDF

Product Web Link

Corporate PDF

05 Brand Name : Asacol/Delzicol

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 415

2015 Revenue in Millions : 618

Growth (%) : -33

Portfolio PDF

Product Web Link

Corporate PDF

06 Brand Name : Canasa/Salofalk

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 196

2015 Revenue in Millions : 156

Growth (%) : 26

Portfolio PDF

Product Web Link

Corporate PDF

07 Brand Name : Asacol/Delzicol

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 113

2018 Revenue in Millions : 177

Growth (%) : -36

Portfolio PDF

Product Web Link

Corporate PDF

08 Brand Name : Canasa/Salofalk

Peptide Therapy Summit

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 48

2018 Revenue in Millions : 187

Growth (%) : -74

Portfolio PDF

Product Web Link